EGCG for Hepatocellular Carcinoma Chemoprevention

NCT06015022 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis, Liver

Interventions

DRUG: Epigallocatechin gallate (EGCG)
OTHER: Placebo

Sponsor

University of Texas Southwestern Medical Center